"Mary's has developed a line of unique products with unparalleled quality, accuracy and an exceptional reputation for effectiveness," said Ben Kovler, Founder and Chairman, GTI.
Denver, CO and MARYLAND (PRWEB) September 01, 2017
MM Technology Holdings, LLC, today announced that it has partnered with Green Thumb Industries (GTI) to produce and distribute its line of Mary's Medicinals cannabis products for patients across Maryland.
"Mary's has developed a line of unique products with unparalleled quality, accuracy and an exceptional reputation for effectiveness," said Ben Kovler, Founder and Chairman, GTI. "Patients deserve the choice of alternative forms of medical cannabis and we're excited to bring this trusted, revolutionary, and highly-targeted suite of medical cannabis delivery options to the patients of Maryland. The patients in Illinois have had tremendous success with Mary’s and we look forward to providing the same access, options, and relief to thousands more.”
Mary's Medicinals has established itself as one of the most trusted and innovative producers of canna-based products in Colorado, and has since expanded into additional states from coast to coast. Mary's was first to offer THCa and CBN products, discovered harvesting techniques for the isolation of CBC, and continues to develop cutting edge approaches for isolating, manufacturing and delivering medicinal cannabis.
"The potential of cannabinoid therapies as a treatment for many conditions is enormous. However, the traditional cannabis products on the market today don't appeal to all patients," said Lynn Honderd, CEO of Mary's Medicinals. "With Mary's unique delivery and accurate dosing mechanisms, patients are finding relief that is more effective, more reliable and more targeted than anything else available. We're pleased to expand our relationship with the highly-regarded and qualified team at GTI to help bring relief to the patients of Maryland."
Available in THC Indica, THC Sativa, THCa, CBN, CBD and CBD/THC, Mary's flagship patches are 2x2 squares, easy to use, and adhere simply to any part of the skin for up to 12 hours of all day (or night) relief. Mary's offers a line of patented high bioavailability transdermal gels and topical compounds that complement its patches. GTI will also distribute Mary's Nutritionals cannabinoid-rich hemp products. Every batch of Mary's products is laboratory tested for quality, accuracy and consistency.
Mary's products are currently available in Illinois, Arizona, Vermont, Oregon, California, Washington, Nevada and Colorado. To find the location nearest you, visit: http://www.marysmedicinals.com/. Look for Mary's products in additional states later this year.
Green Thumb Industries (GTI) is a national cannabis cultivator, processor and dispensary operator dedicated to providing dignified access to safe and effective cannabis nationwide, while giving back to the communities in which they operate. GTI's team of experienced cannabis processing operators bring unmatched expertise, superior quality, and transparency to patients in need. More information is available at: http://GTIgrows.com/
About Mary's Medicinals:
Mary's Medicinals is a wellness company innovating at the intersection of engineering and horticulture. Mary's is focused on transforming how people view and utilize cannabis, developing products that isolate the benefits of cannabis and other vital plant extracts for optimum patient care Mary's Medicinals and Mary's Nutritionals are affiliates of MM Technology Holdings, LLC. More information is available at: http://www.marysmedicinals.com
The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficiency of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. If you are taking any medication or are under treatment for any disease, please consult your health care professional about potential interactions or other possible complications before using these products. The Federal Food, Drug and Cosmetic Act requires this notice.